VEGFA and neoplasm: Although VEGF-A production by tumor cells has been correlated with poor prognosis, pharmacological VEGF-A blockade has shown limited therapeutic success; one likely reason is that VEGF-A from non-endothelial stromal populations can enable tumor survival (Shojaei et al., 2008).